Publicacións nas que colabora con Jose Luis Fuster Soler (1)

2016

  1. Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing

    OncoImmunology, Vol. 5, Núm. 4